US BROKER MOVES: AMAT upgraded at Susquehanna; SNOW downgraded at Barclays

• Advanced Energy (AEIS) Upgraded to Positive at Susquehanna; PT USD 300
• Airbnb (ABNB) Upgraded to Buy at B Riley; PT USD 170
• Akamai (AKAM) Upgraded to Overweight at Morgan Stanley; PT USD 115
• Albemarle (ALB) Upgraded to Sector Outperform at Scotiabank; PT USD 200
• Amphenol (APH) Upgraded to Overweight at Barclays
• Appian (APPN) Upgraded to Overweight at Morgan Stanley
• Applied Materials (AMAT) Upgraded to Positive at Susquehanna; PT USD 400
• Comcast (CMCSA) Upgraded to Buy at BofA; PT USD 37
• Conoco (COP) Upgraded to Overweight at Wells Fargo; PT USD 132
• Crinetics Pharma (CRNX) Upgraded to Buy at Goldman; PT USD 67
• Datadog (DDOG) Upgraded to Overweight at Morgan Stanley; PT USD 180
• Frontline PLC (FRO) Upgraded to Buy at Clarksons; PT USD 28.33
• Liberty Formula One (FWONA) Upgraded to Outperform at Bernstein; PT USD 111
• Oportun (OPRT) Upgraded to Neutral at JPMorgan; PT USD 5.50
• Pebblebrook (PEB) Upgraded to Outperform at Baird; PT USD 15
• Pool Corp (POOL) Upgraded to Outperform at Baird; PT USD 320
• Rocket Cos. (RKT) Upgraded to Neutral at JPMorgan; PT USD 24
• Trade Desk (TTD) Upgraded to Neutral at MoffettNathanson LLC; PT USD 39
• Trex (TREX) Upgraded to Buy at DA Davidson; PT USD 50
• Vertex Pharmaceuticals (VRTX) Upgraded to Outperform at Bernstein

• Allstate (ALL) Downgraded to Hold at TD Cowen; PT USD 231
• American Electric Power (AEP) Downgraded to Neutral at BofA
• American Woodmark (AMWD) Downgraded to Neutral at Baird; PT USD 60
• Amkor Technology (AMKR) Downgraded to Neutral at UBS; PT USD 55
• Arrow Financial (AROW) Downgraded to Market Perform at Hovde Group
• Axalta (AXTA) Downgraded to Neutral at UBS; PT USD 35
• Brunswick (BC) Downgraded to Hold at Texas Capital; PT USD 90
• CrowdStrike (CRWD) Downgraded to Sector Weight at KeyBanc
• Datadog (DDOG) Downgraded to Sell at Goldman
• DoubleVerify (DV) Downgraded to Equal-Weight at Barclays; PT USD 12
• Gitlab (GTLB) Downgraded to Equal-Weight at Morgan Stanley; PT USD 42
• Gitlab (GTLB) Downgraded to Underweight at Barclays; PT USD 34
• HomeTrust Banc (HTB) Downgraded to Market Perform at Hovde Group
• Nutanix (NTNX) Downgraded to Equal-Weight at Morgan Stanley
• OneMain (OMF) Downgraded to Underweight at JPMorgan; PT USD 65
• Perimeter Solutions (PRM) Downgraded to Neutral at UBS; PT USD 31
• Range Resources (RRC) Downgraded to Equal-Weight at Wells Fargo; PT USD 43
• Seadrill (SDRL) Downgraded to Sell at Citi; PT USD 32
• SLM (SLM) Downgraded to Underweight at JPMorgan; PT USD 25
• Snowflake (SNOW) Downgraded to Equal-Weight at Barclays; PT USD 250
• Sunstone Hotel (SHO) Downgraded to Neutral at Baird; PT USD 10
• Triumph Financial Inc (TFIN) Downgraded to Neutral at B Riley; PT USD 70

• Allot Ltd (ALLT) Initiated at New Overweight at Cantor; PT USD 15
• Andersen Group (ANDG) Initiated at New Outperform at William Blair
• Andersen Group (ANDG) Initiated at New Buy at Deutsche Bank; PT USD 30
• Andersen Group (ANDG) Initiated at New Buy at Truist Secs; PT USD 32
• Andersen Group (ANDG) Initiated at New Equal-Weight at Wells Fargo; PT USD 25
• Andersen Group (ANDG) Initiated at New Outperform at Baird; PT USD 40
• Andersen Group (ANDG) Initiated at New Buy at UBS; PT USD 28
• Andersen Group (ANDG) Initiated at New Equal-Weight at Morgan Stanley; PT USD 22
• CBIZ (CBZ) Initiated at New Hold at Deutsche Bank; PT USD 60
• Claritev Corp (CTEV) Initiated at New Buy at Guggenheim; PT USD 43
• Fulcrum Therapeutics (FULC) Initiated at New Overweight at JPMorgan; PT USD 20
• Hims & Hers Health (HIMS) Initiated at New Inline at Evercore ISI; PT USD 33
• Medline (MDLN) Initiated at New Outperform at Bernstein; PT USD 49
• Medline (MDLN) Initiated at New Buy at BTIG; PT USD 50
• Medline (MDLN) Initiated at New Buy at TD Cowen; PT USD 46
• Medline (MDLN) Initiated at New Outperform at William Blair
• Medline (MDLN) Initiated at New Outperform at Mizuho Securities; PT USD 48
• Medline (MDLN) Initiated at New Equal-Weight at Wells Fargo; PT USD 42
• Medline (MDLN) Initiated at New Overweight at Barclays; PT USD 50
• Medline (MDLN) Initiated at New Buy at Truist Secs; PT USD 52
• Medline (MDLN) Initiated at New Neutral at Rothschild & Co Redburn; PT USD 42
• Medline (MDLN) Initiated at New Outperform at Baird; PT USD 48
• Medline (MDLN) Initiated at New Overweight at JPMorgan; PT USD 50
• Medline (MDLN) Initiated at New Buy at UBS; PT USD 48
• Medline (MDLN) Initiated at New Buy at Stifel; PT USD 46
• Medline (MDLN) Initiated at New Buy at Jefferies; PT USD 50
• Medline (MDLN) Initiated at New Outperform at BMO; PT USD 45
• Medline (MDLN) Initiated at New Buy at Goldman; PT USD 49
• Medline (MDLN) Initiated at New Overweight at Piper Sandler; PT USD 50
• Medline (MDLN) Initiated at New Outperform at RBC; PT USD 47
• Medline (MDLN) Initiated at New Outperform at Leerink; PT USD 48
• Medline (MDLN) Initiated at New Overweight at Morgan Stanley; PT USD 48
• Netflix (NFLX) Initiated at New Buy at HSBC; PT USD 107
• Neumora Therapeutics (NMRA) Initiated at New Outperform at Leerink; PT USD 8

The upgrades of Applied Materials (AMAT) at Susquehanna and other names signal a bullish sentiment in the semiconductor industry, especially with AMAT receiving a positive outlook and a significant price target. Conversely, the downgrade of Snowflake (SNOW) at Barclays may indicate a more cautious stance towards its growth prospects, which could weigh on sentiment in the tech sector, particularly for growth stocks. The overall market reaction will likely depend on the credibility of these firms and how much of this sentiment is already priced in.